Skip to main content
Premium Trial:

Request an Annual Quote

Admera Taps N-of-One for Clinical Interpretation of OncoGxOne Oncology Panel

NEW YORK (GenomeWeb) – N-of-One announced today that it has signed an agreement with molecular diagnostics company Admera Health to provide clinical interpretation for patients tested with Admera's OncoGxOne 64-gene oncology panel.

N-of-One will analyze the results of each OncoGxOne test to identify the most relevant therapeutic options for each patient based on scientific and clinical evidence. The OncoGxOne is a next-generation sequencing panel that detects 64 of the most common mutations — including SNVs, insertions and deletions, copy number variants, and gene fusions associated with all current FDA approved targeted therapies and multiple registered clinical trials — found in several cancer types.

Financial terms of the deal were not disclosed.

"We are very pleased to be able to offer N-of-One's patient-specific analysis with our OncoGxOne cancer panel," said Admera Health Lab Director James Dermody in a statement. "Admera Health's goal of easily integrating into routine clinical practice is supported by partnering with N-of-One. With N-of-One, we can provide oncologists with an Admera Health diagnostic report that is clear, actionable, and based on the latest scientific evidence."

N-of-One has signed similar deals in recent months, including a global agreement in November 2015 to provide clinical and scientific evidence that supports personalized treatment recommendations made on the basis of WuXi Nextcode's tumor-normal sequence interpretation, and a deal earlier this month to provide Macrogen with clinical interpretation services for its clinical next-generation sequencing-based cancer panels.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.